US HR271 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 104-1)
Status: Introduced on March 29 2019 - 25% progression, died in chamber
Action: 2019-04-03 - Motion to reconsider laid on the table Agreed to without objection.
Text: Latest bill text (Engrossed) [PDF]
Status: Introduced on March 29 2019 - 25% progression, died in chamber
Action: 2019-04-03 - Motion to reconsider laid on the table Agreed to without objection.
Text: Latest bill text (Engrossed) [PDF]
Summary
This resolution urges the Department of Justice (DOJ) to cease its efforts against the Patient Protection and Affordable Care Act (PPACA) and reverse its position in Texas v. United States. (On March 25, 2019, DOJ submitted a letter to the appellate court agreeing with the lower court's decision that PPACA should be struck in its entirety).
Title
Condemning the Trump Administration's Legal Campaign to Take Away Americans' Health Care.
Sponsors
Roll Calls
2019-04-03 - House - On agreeing to the resolution RC# 146 (Y: 240 N: 186 NV: 6 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2019-04-03 | House | Motion to reconsider laid on the table Agreed to without objection. |
| 2019-04-03 | House | On agreeing to the resolution Agreed to by the Yeas and Nays: 240 - 186, 1 Present (Roll no. 146). (text: CR 4/2/2019 H2956-2957) |
| 2019-04-03 | House | Considered as unfinished business. (consideration: CR H3002-3003) |
| 2019-04-02 | House | The previous question was ordered pursuant to the rule. |
| 2019-04-02 | House | DEBATE - The House proceeded with one hour of debate on H. Res. 271. |
| 2019-04-02 | House | Rule provides for consideration of S.J. Res. 7 and H. Res. 271. Rule provides for the previous question to be considered as ordered without intervening motions for both measures except for one hour of debate; one motion to recommit S.J. Res. 7 is allowed. It shall be in order at any time on the legislative day of April 4, 2019 for the Speaker to entertain motions that the House suspend the rules. |
| 2019-04-02 | House | Considered under the provisions of rule H. Res. 274. (consideration: CR H2956-2969) |
| 2019-04-02 | House | Rule H. Res. 274 passed House. |
| 2019-04-01 | House | Rules Committee Resolution H. Res. 274 Reported to House. Rule provides for consideration of S.J. Res. 7 and H. Res. 271. Rule provides for the previous question to be considered as ordered without intervening motions for both measures except for one hour of debate; one motion to recommit S.J. Res. 7 is allowed. It shall be in order at any time on the legislative day of April 4, 2019 for the Speaker to entertain motions that the House suspend the rules. |
| 2019-04-01 | House | Referred to the Subcommittee on Health. |
| 2019-03-29 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2019-03-29 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2019-03-29 | House | Introduced in House |
Same As/Similar To
HR274 (Related) 2019-04-02 - Motion to reconsider laid on the table Agreed to without objection.
SR134 (Related) 2019-04-02 - Referred to the Committee on the Judiciary. (text: CR S2192-2193)
SR134 (Related) 2019-04-02 - Referred to the Committee on the Judiciary. (text: CR S2192-2193)
Subjects
Constitution and constitutional amendments
Health
Health care costs and insurance
Health care coverage and access
Health programs administration and funding
Inflation and prices
Judicial review and appeals
Prescription drugs
Health
Health care costs and insurance
Health care coverage and access
Health programs administration and funding
Inflation and prices
Judicial review and appeals
Prescription drugs
